Merge Healthcare Incorporated (Chicago), a health IT interoperability solutions company, announced that Omnicare Clinical Research, a full service Contract Research Organization (CRO) and subsidiary of Omnicare Inc., will work with Merge’s clinical trial solutions in a major new clinical trial. A long-standing user of the Merge EDC clinical trials application, Omnicare Clinical Research will now will implement Merge CIMS as a part of its end-to-end solution for image management of oncology, cardiology and ophthalmology clinical trials.
Omnicare will use this integrated imaging solution paired with Merge EDC to conduct an upcoming study for a leading pharmaceutical company specializing in molecular diagnostics for oncology research. This global colorectal cancer trial will collect and review 2,750 exams from 550 patients at 40 sites over 5 years. This streamlined solution, built on Merge CIMS, was selected for its ability to lower costs, reduce the time to deliver results by up to 10 times relative to industry standards, and provide complete transparency to all of the stakeholders in the trial.
Along with Merge CIMS, Omnicare plans to leverage AG Mednet’s image transfer technology and leading radiology expertise from Intrinsic Imaging to build a complete virtual imaging core lab solution. The Merge CIMS role is to automate the full workflow of image submission, image storage in a vendor-neutral DICOM archive, and image review and analysis. This allows the imaging component of any study to be completed more efficiently and economically, while also integrating fully with any EDC system to provide end-to-end visibility to all data in a clinical trial.